Jeannick Cizeau

2.7k citations

28 papers · 2.3k indexed · 1 hit paper · h-index 15

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Epidemiology top 5%
- Autophagy in Disease and Therapy

Papers in

Biotechnology 10
- Transgenic Plants and Applications 8
Immunology 14
- Toxin Mechanisms and Immunotoxins 11

Co-authors: Christine Vande Velde Sara J. Israels D. Dubik Arnold H. Greenberg Chen Gao Reena Ray Jae Hoon Park Harry B. Greenberg
Journals: Cancer Research (4 papers)The Journal of Urology (3 papers)Journal of Immunotherapy (2 papers)Journal of Biological Chemistry (2 papers)Oncogene (2 papers)
Partner nations: Canada France United States

In The Last Decade

Jeannick Cizeau

27 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

BNIP3 and Genetic Control of Necrosis-Like Cell Death through the Mitochondrial Permeability Transition Pore 2000 · 515 citations

Peers

Countries citing papers authored by Jeannick Cizeau

Since Specialization

Citations

This map shows the geographic impact of Jeannick Cizeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeannick Cizeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeannick Cizeau more than expected).

Fields of papers citing papers by Jeannick Cizeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeannick Cizeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeannick Cizeau. The network helps show where Jeannick Cizeau may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jeannick Cizeau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jeannick Cizeau Line = papers co-authored together Jeannick Cizeau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	PD03-02 PHASE 3 RESULTS OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER The Journal of Urology ·Neal D. Shore, Michael A. O’Donnell, Thomas E. Keane, Michael A.S. Jewett, Girish S. Kulkarni, Rian J. Dickstein, В В Пошибаев, Curtis Dunshee, Laurence Belkoff, Rachelle L. Dillon, Jeannick Cizeau, Wassim Kassouf	2020	26
2	Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation Surgical Oncology ·Leonora S. F. Boogerd, Martin C. Boonstra, Hendrica A.J.M. Prevoo, Henricus J.M. Handgraaf, Peter J.K. Kuppen, Cornelis J.�H. van de Velde, Alexander Fish, Robert A. Cordfunke, A. Rob P.M. Valentijn, Gábor Sira, Glen C. MacDonald, Jeannick Cizeau, 正司小原, Alex Y. Dobrinsky, Jacobus Burggraaf, Cornelis F.M. Sier, Alexander L. Vahrmeijer	2018	29
3	Abstract 79: Trastuzumab and C6.5 diabody armed with deBouganin overcome drug resistance to ADCs comprised of anti-microtubule agents Cancer Research ·Gulliermo Randle, Rachelle L. Dillon, 正司小原, Gregory P. Adams, Glen C. MacDonald, Jeannick Cizeau	2017	1
4	Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance Journal of Immunotherapy ·Rachelle L. Dillon, Gulliermo Randle, 正司小原, Gregory P. Adams, Joycelyn Entwistle, Glen C. MacDonald, Jeannick Cizeau	2016	19
5	Preclinical Evaluation of VB6-845: An Anti-EpCAM Immunotoxin with Reduced Immunogenic Potential Cancer Biotherapy and Radiopharmaceuticals ·Joycelyn Entwistle, Jennifer G. Brown, Gulliermo Randle, Jeannick Cizeau, Glen C. MacDonald	2012	19
6	Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentation Protein Expression and Purification ·正司小原, S. Fricke, Jeannick Cizeau, Joycelyn Entwistle, Glen C. MacDonald	2011	11
7	A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients Drug Design Development and Therapy ·Andreea, Mark Kowalski, Крапивина Елена Александровна, Jeannick Cizeau, 哲夫橋本, Pedro Affonso Nóbrega, Wendy W. Chapman	2010	57
8	Preclinical Assessment of an Anti-EpCAM Immunotoxin: Locoregional Delivery Provides a Safer Alternative to Systemic Administration Cancer Biotherapy and Radiopharmaceuticals ·Jennifer G. Brown, Michèle Rasamoelisolo, Maureen Spearman, Denis G. Bosc, Jeannick Cizeau, Joycelyn Entwistle, Glen C. MacDonald	2009	14
9	Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin Journal of Immunotherapy ·Jeannick Cizeau, Michael C. L'E. Orme, Jennifer G. Brown, Joycelyn Entwistle, Glen C. MacDonald	2009	63
10	Pre-clinical safety assessment of VB4-845, an EpCAM binding immunoconjugate Cancer Research ·Jhony Fabián Gaviria Muñoz, Jennifer G. Brown, Samee Haider, Jeannick Cizeau, Denis G. Bosc, Joycelyn Entwistle, R.S. Barberino, Glen C. MacDonald	2008	1
11	Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3 Autophagy ·Meghan B. Azad, Yongqiang Chen, Elizabeth S. Henson, Jeannick Cizeau, Eileen McMillan‐Ward, Sara J. Israels, Spencer B. Gibson	2008	290
12	StARD13(Dlc-2) RhoGap Mediates Ceramide Activation of Phosphatidylglycerolphosphate Synthase and Drug Response in Chinese Hamster Ovary Cells Molecular Biology of the Cell ·Grant M. Hatch, Yuan Gu, Fred Y. Xu, Jeannick Cizeau, Cristián Céspedes Viñuela, Yacov Yu. Nikitin, Pedro Affonso Nóbrega, Michael Mowat	2007	11
13	VB1-008: Identification of a fully-human antibody specific for CD44E and CD44-isoform-3 Cancer Research ·Jeannick Cizeau, Tursunova Maftuna Abidzhanovna, Joycelyn Entwistle, Michèle Rasamoelisolo, R.S. Barberino, Glen C. MacDonald	2006	0
14	BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF Oncogene ·Yan Xu, Jeannick Cizeau, Eileen McMillan‐Ward, Sara J. Israels, Yaofa LiMinami Yoda, ELISABETTA GYULAI, Lorrie A. Kirshenbaum, Spencer B. Gibson	2003	176
15	The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanism Oncogene ·Jeannick Cizeau, Reena Ray, Gao Chen, R. Daniel Gietz, Arnold H. Greenberg	2000	38
16	BNIP3 Heterodimerizes with Bcl-2/Bcl-XL and Induces Cell Death Independent of a Bcl-2 Homology 3 (BH3) Domain at Both Mitochondrial and Nonmitochondrial Sites Journal of Biological Chemistry ·Reena Ray, Chen Gao, Christine Vande Velde, Jeannick Cizeau, Jae Hoon Park, John C. Reed, R. Daniel Gietz, Arnold H. Greenberg	2000	296
17	Nix and Nip3 Form a Subfamily of Pro-apoptotic Mitochondrial Proteins Journal of Biological Chemistry ·Chen Gao, Jeannick Cizeau, Christine Vande Velde, Jae Hoon Park, Santhanakrishnan Srinivasan, Shay‐Lee Bolton, Lianfa Shi, D. Dubik, Arnold H. Greenberg	1999	262
18	Large deletions induced in the white gene of Drosophila melanogaster by the antitumoral drug cis-dichlorodiammineplatinum(II): influence of non-homologous recombination Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·Jeannick Cizeau, Martine Decoville, M. Leng, Daniel Locker	1996	6
19	Deletions induced in the white and vermilion genes of Drosophila melanogaster by the antitumor drug cis-dichlorodiammineplatinum(II) Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Jeannick Cizeau, Martine Decoville, M. Leng, Daniel Locker	1994	14
20	Synthesis of aryl glycosides as vir gene inducers of Agrobacterium tumefaciens Carbohydrate Research ·Didier Delay, Jeannick Cizeau, Franck Delmotte	1992	5

About Jeannick Cizeau

Jeannick Cizeau is a scholar working on Biotechnology, Immunology, Aging, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 28 papers that have together received 2.3k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (11 papers), Transgenic Plants and Applications (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Cell death mechanisms and regulation (5 papers), Plant tissue culture and regeneration (4 papers), Glycosylation and Glycoproteins Research (3 papers), Mitochondrial Function and Pathology (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Cancer Research (525 citations), Epidemiology (851 citations), Molecular Biology (1.5k citations), Biotechnology (126 citations) and Immunology (302 citations). Jeannick Cizeau has collaborated with scholars based in Canada, France and United States. Frequent co-authors include Christine Vande Velde, Sara J. Israels, D. Dubik, Arnold H. Greenberg, Chen Gao, Reena Ray, Jae Hoon Park, Harry B. Greenberg, Thomas L. Brown and Judie B. Alimonti. Their work appears in journals such as Cancer Research, The Journal of Urology, Journal of Immunotherapy, Journal of Biological Chemistry and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact